drugset
drugset / Trial / NCT00406406

Study Evaluating SKI-606 Administered to Healthy Subjects

NCT00406406 ↗

Phase 1 Completed Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedSingle-groupDouble-blindTreatment

Summary

Safety and tolerability of SKI-606 in healthy subjects; the influence of food intake on the same.

Timeline

Start
2006-11
Primary completion
—
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosutinib Small molecule — Oral

Indications

No indication recorded.